MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

09 Feb 2024 Evaluate
Net sales declined -18.10%  to  Rs. 1085.73 million from Rs. 1325.73 millions.Profit after Tax for the quarter ended December 2023 saw a decline of -67.02% from Rs. 167.48 millions to Rs. 55.24  millions.A decline of 203.33 millions was observed in the OP in the quarter ended December 2023 from 305.05 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1085.73 1325.73 -18.10 3395.20 4916.86 -30.95 6732.92 6798.89 -0.97
Other Income 7.98 0.71 1023.94 22.33 8.69 156.96 15.98 14.44 10.66
PBIDT 203.33 305.05 -33.35 624.63 902.07 -30.76 1084.44 1199.45 -9.59
Interest 66.54 53.68 23.96 236.69 115.92 104.18 228.72 126.24 81.18
PBDT 136.79 251.37 -45.58 387.94 786.15 -50.65 855.72 1073.21 -20.27
Depreciation 73.54 44.30 66.00 203.21 125.14 62.39 273.55 176.36 55.11
PBT 63.25 207.07 -69.45 184.73 661.01 -72.05 582.17 896.85 -35.09
TAX 8.01 39.59 -79.77 7.99 137.21 -94.18 151.92 182.98 -16.97
Deferred Tax -5.55 -1.21 358.68 -5.57 -3.49 59.60 -11.66 -6.14 89.90
PAT 55.24 167.48 -67.02 176.74 523.80 -66.26 430.25 713.87 -39.73
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 18.73 23.01 -18.61 18.40 18.35 0.28 16.11 17.64 -8.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..